Latest News and Press Releases

Cosmos Health reported Q2 2025 results with 11.7% revenue growth and H1 gross profit up 53% to $3.21M, remaining on track with profitability targets

Cosmos Health Makes Initial $1M Ethereum (ETH) Purchase Under Digital Asset Treasury Strategy

Cosmos Health secures financing of up to $300 million to develop an ETH-backed treasury, with remaining proceeds for growth and general working capital

Cosmos Health expands into the U.S. with local manufacturing to reduce tariff risks, partnering with New Jersey-based DolCas Biotech for production.

Cosmos Health delivered adjusted profitability in Q1 2025, with gross profit up 54% and cash burn down 95%, nearing breakeven.

Cosmos Health delivered adjusted profitability in Q1 2025, with gross profit up 54% and cash burn down 95%, nearing breakeven.

Cosmos Health lands follow-up order for 80K Sky Premium Life units in UAE after initial 130K sell-out, supporting 5-year goal of 3M+ units.

Cosmos Health is eligible for an additional 180 calendar day period to regain compliance with the Nasdaq’s minimum bid price requirement.

Greg Siokas has increased his stake in the Company by acquiring 1,466,764 common shares for $526,000.

FY 2024 performance was marked by revenue growth, an increase in R&D investments, and a substantial reduction in operating expenses.